Biologics & Biosimilars

Coronavirus Vaccination Disparities Widen, FDA Warns Against Baby Formula

March 9, 2022 - In a promising move for consumers, the Food and Drug Administration (FDA) has accepted an application for Abrilada, a biosimilar that will compete with Humira. Elsewhere within the administration, regulators are investigating a possible baby formula contamination that may have caused the death of two infants. Meanwhile, during his first State of...


More Articles

Medicare Hospital Reimbursement Set for 2.5% Increase in 2022

by Kyle Murphy, PhD

Let me tell you: A week away from work feels great. Now it's time to turn our attention back to healthcare. Medicare’s Inpatient Payments Will Increase 2.5% in 2022 CMS has finalized an...

Do Not Sell or Share My Personal Information
©2012-2024 TechTarget, Inc. Xtelligent Healthcare Media is a division of TechTarget. All rights reserved. HealthITAnalytics.com is published by Xtelligent Healthcare Media a division of TechTarget.